Indefinite Delivery Contract SPE2DX15D9929

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, which runs through December 31, 2025, enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The task orders provided demonstrate DMS Pharmaceutical Group's ability to fulfill delivery orders for specific pharmaceutical items, including Levofloxacin 500 mg tablets, Lidocaine HCL 2% vials, Cyclobenzaprine 10 mg tablets, Mupirocin 2% ointment, and Epinephrine 0.3 mg auto-injectors. These task orders, which do not utilize any set-aside designations, are priced on a firm fixed-price basis and have completion dates ranging from December 2018 to January 2019. By securing this single-award IDC, DMS Pharmaceutical Group has positioned itself as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.